Curcumin + piperine

Curcumin + piperine has been studied in 8 papers since 2018: 1 trial in people, 1 in animals, 6 reviews; 3 in the past year. The newest paper, Nov 16, 2026: “The efficacy of non-pharmacological interventions on non-alcoholic fatty liver disease in adults: An umbrella meta-analysis”.

Intervention

8 papers study it15 findingsUpdated

1 new paper in 30 daysSee all 8 papers on curcumin + piperine

At a glance

Independent labs found the same change in people. 5 independent labs in 5 countries.

“Curcumin + piperine decreased waist circumference (p = 0.026), systolic blood pressure (p = 0.001), total cholesterol (p = 0.004), low-density lipoprotein-cholesterol (p = 0.006), FBG (p = 0.002)”
Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trialPhytotherapy research : PTR2023doi:10.1002/ptr.7764

None of its findings points the other way.

Humans: replicated by independent labs. Mice: a single group. Cells and worms or flies: nothing yet.
  • 5 independent labs in 5 countries
  • Funders: National Institute for Medical Research Development and 5 more
  • 2 of 14 findings with company ties
  • Human trial1
  • Animals1

Studies in people

1 study gave curcumin + piperine to people and measured what changed.

What changedDesignPeopleSource

down: Decreases waist circumferencep = 0.026

down: Decreases systolic blood pressurep = 0.001

down: Decreases total cholesterolp = 0.004

Randomized trial12 weeksIn NAFLD patients with moderate-to-high hepatic steatosisPhytotherapy research : PTR, Feb 17, 2023

What did studies of curcumin + piperine find?

14

Studies of curcumin + piperine measured 14 outcomes, among them total cholesterol, flare-free survival and inflammation.

Total cholesterol

downin humans2

2 studies
  1. Curcumin + piperine decreases total cholesterol in NAFLD patients with moderate-to-high hepatic steatosis (p = 0.004).

    Human trialin NAFLD patients with moderate-to-high hepatic steatosis500 mg/day curcumin plus 5 mg/day piperine12 weeks

  2. Curcumin + piperine decreases total cholesterol in patients suffering from metabolic syndrome.

    Reviewin patients suffering from metabolic syndrome

More on Total cholesterol

Flare-free survival

no changein humans1

1 study
  1. Curcumin + piperine showed no clear effect on flare-free survival in phase III rheumatoid arthritis maintenance trial.

    Reviewin phase III rheumatoid arthritis maintenance trial

Inflammation

downin humans1

1 study
  1. Curcumin + piperine decreases inflammation in humans.

    Reviewacross metabolic syndrome, type 2 diabetes, hemodialysis, inflammatory bowel disease, CABG recovery, and sepsis

More on Inflammation

Bioavailability

upin reviews1

1 study
  1. Curcumin + piperine increases bioavailability (up to 20-fold).

    Review

Body mass index

no changein humans1

1 study
  1. Curcumin + piperine showed no clear effect on body mass index in patients with prediabetes and type 2 diabetes mellitus (MD = -0.41, 95% CI [-0.85 to 0.03], p = 0.07).

    Reviewin patients with prediabetes and type 2 diabetes mellitus

HOMA-IR

no changein humans1

1 study
  1. Curcumin + piperine showed no clear effect on HOMA-IR in patients with prediabetes and type 2 diabetes mellitus (MD = -0.36, 95% CI [-0.77 to 0.05], p = 0.09).

    Reviewin patients with prediabetes and type 2 diabetes mellitus

More on HOMA-IR

Fasting plasma glucose

no changein humans1

1 study
  1. Curcumin + piperine showed no clear effect on fasting plasma glucose in patients with prediabetes and type 2 diabetes mellitus (MD = -7.61, 95% CI [-15.26, 0.03], p = 0.05).

    Reviewin patients with prediabetes and type 2 diabetes mellitus

More on Fasting plasma glucose

Liver stiffness

no changein humans1

1 study
  1. Curcumin + piperine showed no clear effect on liver stiffness in NAFLD patients with moderate-to-high hepatic steatosis (p > 0.05).

    Human trialin NAFLD patients with moderate-to-high hepatic steatosis500 mg/day curcumin plus 5 mg/day piperine12 weeks

More on Liver stiffness

Alanine transaminase

downin humans1

1 study
  1. Curcumin + piperine decreases alanine transaminase in NAFLD patients with moderate-to-high hepatic steatosis (p = 0.007).

    Human trialin NAFLD patients with moderate-to-high hepatic steatosis500 mg/day curcumin plus 5 mg/day piperine12 weeks

More on Alanine transaminase

Systolic blood pressure

downin humans1

1 study
  1. Curcumin + piperine decreases systolic blood pressure in NAFLD patients with moderate-to-high hepatic steatosis (p = 0.001).

    Human trialin NAFLD patients with moderate-to-high hepatic steatosis500 mg/day curcumin plus 5 mg/day piperine12 weeks

More on Systolic blood pressure

Waist circumference

downin humans1

1 study
  1. Curcumin + piperine decreases waist circumference in NAFLD patients with moderate-to-high hepatic steatosis (p = 0.026).

    Human trialin NAFLD patients with moderate-to-high hepatic steatosis500 mg/day curcumin plus 5 mg/day piperine12 weeks

More on Waist circumference

All 14

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 13 papers in 12 months